Literature DB >> 31970492

An update on the CNS manifestations of brain tumor polyposis syndromes.

Byungjin Kim1,2, Uri Tabori1,3,4, Cynthia Hawkins5,6,7.   

Abstract

Cancer predisposition syndromes are associated with an increased risk of developing primary malignancies. Here we discuss those which are associated with an increased risk of tumors of the central nervous system (CNS) and gastrointestinal (GI) tract. These can be grouped into those in which the CNS tumors predominate versus those in which the GI cancers predominate. The former include constitutional mismatch repair deficiency (CMMRD) syndrome, Li-Fraumeni syndrome (LFS), and Cowden syndrome (CS) while the latter include familial adenomatosis polyposis 1 (FAP1), Lynch syndrome and polymerase proofreading-associated polyposis syndrome (PPAP). Tumor specificity does exist as medulloblastoma occur in FAP, LFS and CMMRD while glioma are most commonly seen in all replication repair-deficient genes and LFS. Choroid plexus carcinoma is strictly observed in LFS while Cowden syndrome patients develop Lhermitte Duclos disease or meningioma. In each syndrome, specific types of low-grade and high-grade gastrointestinal cancers can occur, but these will be discussed elsewhere. Underlying cancer predisposition syndromes are important to consider when faced with brain tumors, particularly in the pediatric and young adult age groups, as identification of an underlying germ line mutation may change the upfront management of the patient and has implications for future cancer surveillance for both the patient and potentially affected family members. Considerations of family history, presence of skin lesions and consanguinity provide valuable information in identifying patients at potential increased risk.

Entities:  

Keywords:  Brain tumor; CMMRD; Cancer predisposition syndrome; MMR

Mesh:

Year:  2020        PMID: 31970492     DOI: 10.1007/s00401-020-02124-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

1.  Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  A Kerpel; M Yalon; M Soudack; J Chiang; A Gajjar; K E Nichols; Z Patay; S Shrot; C Hoffmann
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

Review 2.  An update on the central nervous system manifestations of familial tumor predisposition syndromes.

Authors:  David A Solomon
Journal:  Acta Neuropathol       Date:  2020-02-03       Impact factor: 17.088

3.  Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.

Authors:  Santiago Cabezas-Camarero; Rebeca Pérez-Alfayate; Vanesa García-Barberán; María Carmen Polidura; María Natividad Gómez-Ruiz; Isabel Casado-Fariñas; Issa Ahmad Subhi-Issa; José Carlos Plaza Hernández; Pilar Garre; Isabel Díaz-Millán; Pedro Pérez-Segura
Journal:  Ther Adv Med Oncol       Date:  2022-06-08       Impact factor: 5.485

4.  Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Authors:  Alisa Förster; Frank Brand; Rouzbeh Banan; Robert Hüneburg; Christine A M Weber; Wiebke Ewert; Jessica Kronenberg; Christopher Previti; Natalie Elyan; Ulrike Beyer; Helge Martens; Bujung Hong; Jan H Bräsen; Andreas Erbersdobler; Joachim K Krauss; Martin Stangel; Amir Samii; Stephan Wolf; Matthias Preller; Stefan Aretz; Bettina Wiese; Christian Hartmann; Ruthild G Weber
Journal:  Acta Neuropathol       Date:  2021-04-30       Impact factor: 17.088

5.  Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas.

Authors:  Liang Hong; Zhi-Feng Shi; Kay Ka-Wai Li; Wei-Wei Wang; Rui Ryan Yang; Johnny Sheung-Him Kwan; Hong Chen; Fang-Cheng Li; Xian-Zhi Liu; Danny Tat-Ming Chan; Wen-Cai Li; Zhen-Yu Zhang; Ying Mao; Ho-Keung Ng
Journal:  Lab Invest       Date:  2022-03-24       Impact factor: 5.662

Review 6.  Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives.

Authors:  Giulia Ceglie; Laura Papetti; Massimiliano Valeriani; Pietro Merli
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

Review 7.  Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas.

Authors:  Giulia Ceglie; Giada Del Baldo; Emanuele Agolini; Martina Rinelli; Antonella Cacchione; Francesca Del Bufalo; Maria Vinci; Roberto Carta; Luigi Boccuto; Evelina Miele; Angela Mastronuzzi; Franco Locatelli; Andrea Carai
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

8.  Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.

Authors:  Yonghui Zhao; Xiang Zhang; Junchao Yao
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

Review 9.  Precision Therapy for Brain Tumors in Hereditary Syndromes.

Authors:  Gerald C Wallace; Madeleine Tjoelker; Kaitlyn Bartley; John W Henson
Journal:  Curr Treat Options Oncol       Date:  2021-07-02

10.  Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.

Authors:  Abigail K Suwala; Damian Stichel; Daniel Schrimpf; Matthias Kloor; Annika K Wefers; Annekathrin Reinhardt; Sybren L N Maas; Christian P Kratz; Leonille Schweizer; Martin Hasselblatt; Matija Snuderl; Malak Sameer J Abedalthagafi; Zied Abdullaev; Camelia M Monoranu; Markus Bergmann; Arnulf Pekrun; Christian Freyschlag; Eleonora Aronica; Christof M Kramm; Felix Hinz; Philipp Sievers; Andrey Korshunov; Marcel Kool; Stefan M Pfister; Dominik Sturm; David T W Jones; Wolfgang Wick; Andreas Unterberg; Christian Hartmann; Andrew Dodgshun; Uri Tabori; Pieter Wesseling; Felix Sahm; Andreas von Deimling; David E Reuss
Journal:  Acta Neuropathol       Date:  2020-11-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.